192 related articles for article (PubMed ID: 7517586)
1. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
Patrassi GM; Viero M; Sartori MT; De Silvestro G; Rossaro L; Burra P; Nolli ML; Piccinni P; Bassi N
Transfusion; 1994 Jun; 34(6):507-11. PubMed ID: 7517586
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
[TBL] [Abstract][Full Text] [Related]
3. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
[TBL] [Abstract][Full Text] [Related]
4. Impact of aprotinin on blood transfusion requirements in liver transplantation.
Smith O; Hazlehurst G; Brozovic B; Rolles K; Burroughs A; Mallett S; Dawson K; Mehta A
Transfus Med; 1993 Jun; 3(2):97-102. PubMed ID: 7690641
[TBL] [Abstract][Full Text] [Related]
5. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.
García-Huete L; Domenech P; Sabaté A; Martínez-Brotons F; Jaurrieta E; Figueras J
Hepatology; 1997 Nov; 26(5):1143-8. PubMed ID: 9362354
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation.
Soilleux H; Gillon MC; Mirand A; Daibes M; Leballe F; Ecoffey C
Anesth Analg; 1995 Feb; 80(2):349-52. PubMed ID: 7529468
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
[TBL] [Abstract][Full Text] [Related]
9. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
[TBL] [Abstract][Full Text] [Related]
10. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
[TBL] [Abstract][Full Text] [Related]
12. Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation.
Frenette L; Cox J; McArdle P; Eckhoff D; Bynon S
Anesth Analg; 1998 Jun; 86(6):1183-6. PubMed ID: 9620500
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience.
Trzebicki J; Kosieradzki M; Flakiewicz E; Kuzminska G; Wasiak D; Pacholczyk M; Lagiewska B; Lisik W; Kosson D; Kulik A; Chmura A; Lazowski T
Transplant Proc; 2011 Jun; 43(5):1725-7. PubMed ID: 21693266
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
[TBL] [Abstract][Full Text] [Related]
16. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.
Murkin JM; Haig GM; Beer KJ; Cicutti N; McCutchen J; Comunale ME; Hall R; Ruzicka BB
J Bone Joint Surg Am; 2000 May; 82(5):675-84. PubMed ID: 10819278
[TBL] [Abstract][Full Text] [Related]
18. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin reduces the need for blood products during liver transplantation.
Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
[TBL] [Abstract][Full Text] [Related]
20. The intra-operative use of trasylol (aprotinin) in liver transplantation.
Mallett SV; Cox D; Burroughs AK; Rolles K
Transpl Int; 1991 Dec; 4(4):227-30. PubMed ID: 1723874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
